Article Details
Retrieved on: 2022-06-16 14:21:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's (RHHBY) (RHHBF) said its medicine crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation which ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here